Miikka Vikkula @mvikkula.bsky.social · 26/09/2026At #ESL. Learning the latest in lymphedema diagnosis and management. #vascern 010
Miikka Vikkula @mvikkula.bsky.social · 21/09/2026The yearly Nordic Society of Vascular Anomalies (NSVA) meeting has started in Oslo. Education and development of new ideas for diagnosis and treatment of vascular anomalies. Thank you for inviting us NSVA. #vascern #vascapa #hevas #cmtc 000
Miikka Vikkula @mvikkula.bsky.social · 08/07/2026The latest edition of Clinics in Plastic Surgery just released. Link to download the VENOUS MALFORMATION chapter by Dr Julien Coulie from our Vascular Anomaly Centre for free until 25/8/2026. Enjoy reading it. #VASCAPA #CMTC #HEVAS #VASCERN #ISSVA authors.elsevier.com/a/1nOYuLPnEr... 000
Miikka Vikkula @mvikkula.bsky.social · 22/05/2026Exciting #ISSVA 2026. 100 presentations, posters, intense discussions and sponsored sessions. A great keynote by Taija Makinen. A touching tribute to the late founder, John Mulliken, underscoring curiosity, accuracy and collaboration. ISSVA Dublin 5-7 May 2027. #VASCERN -VASCA #VASCAPA #HEVAS #CMTC 000
Miikka Vikkula @mvikkula.bsky.social · 20/05/2026#ISSVA 2026 has started. Great to meet again friends and colleagues to discuss #vascular #anomalies. #vascapa #hevas #cmtc #deduveinstitute #Vascern 000
Miikka Vikkula @mvikkula.bsky.social · 12/05/2026Exciting 1st day at #iDR26 on #drug #repurposing. Academics, companies, funders, policymakers & patients, gathered to discuss how to #repurpose #medicines for #diseases with unmet medical needs, incl. #vascular anomalies. #VASCERN #VASCAPA #HEVAS #CMTC #Eurordis #WELRI #deDuveInstitute #FNRS #ISSVA 010
Miikka Vikkula @mvikkula.bsky.social · 28/04/2026Fabian’s great work: Volumetric perfusion fraction change in MR angiography for monitoring sclerotherapy-related changes in peripheral #venous #malformations published. Free access until 13/6/2026: authors.elsevier.com/c/1m~tx,GNpk... #VASCERN #VASCAPA #HEVAS #CMTC #Welbio #deDuveInstitute #ISSVA 000
Miikka Vikkula @mvikkula.bsky.social · 26/04/2026What a beautiful, heartfelt day of remembrance in honour of Dr. John B. Mulliken. Colleagues, patients and friends came together to share their treasured memories. In tribute, Harvard Medical School lowered its flag to half-mast. #VASCERN #VASCAPA #RADIORG #HEVAS #CMTC #Eurordis #Welbio #uclouvain 021
Miikka Vikkula @mvikkula.bsky.social · 20/04/2026A great #ESVM (#European Society of @Vascular Medicine) meeting and #VASCERN session, Lausanne. Interesting discussions with Drs Jondeau, Quéré, & Mirault. Fantastic networking at #Olympic Museum. Looking forward to follow-up the action points. #vascapa #hevas #cmtc #eurordis #deduveinstitute. 000
Miikka Vikkula @mvikkula.bsky.social · 12/04/2026An interesting session on #vascular anomalies at the Society of #Interventional #radiology (#SIR) meeting in Toronto. Met new enthusiastic younger colleagues! #VASCAPA #CMTC #HEVAS #VASCERN 011
Miikka Vikkula @mvikkula.bsky.social · 18/03/2026Our latest review, 'Current and Emerging Pharmacotherapies for Vascular Malformations', is online. First 50 can download the PDF for free via the link. Thank you, Emmanuel Seront, for putting it together! #VASCAPA #HEVAS #CMTC #VASCERN #RADIOORG #EURORDIS #EVBO www.tandfonline.com/eprint/QGPRV... 031
Miikka Vikkula @mvikkula.bsky.social · 24/02/2026It was a great annual #Crick #Rare Disease Conference 2026. Learned so much new, made novel contacts, and of course, discussed #precision #therapies for #vascular, and more specifically, #lymphatic anomalies. Organised by @Veronica K. #VASCERN #vascapa #hevas #eurordis #CMTC 010
Miikka Vikkula @mvikkula.bsky.social · 11/02/2026The VAS European Book on Angiology/Vascular Medicine (ISBN: 978-3-031-82232-2) is now published accessible in print and online ! #VASCAPA #HEVAS #CMTC #VASCERN #EURORDIS 010
Miikka Vikkula @mvikkula.bsky.social · 06/02/2026Laurence and I were honoured to participate in the vascular anomaly session at the French Academy of Medicine on 2 February 2026, organised by Prof. Anne Dompmartin. Our presentations were dedicated to our late Mentor, Dr John B. Mulliken. 000
Miikka Vikkula @mvikkula.bsky.social · 17/12/2025Congratulations Emmanuel on showing how #sirolimus treatment can be adapted. #patients with #slow-#flow #vascular #malformations have #symptom reduction even with #intermittent dosing. A big step forward in the #multimodal management of VAs. #VASCERN #VASCAPA #CMTC #HEVAS #ISSVA #EVDays #Lymph 030
Miikka Vikkula @mvikkula.bsky.social · 15/12/2025The virtual #European #Angiology Days (EADays) 2025 are just over. Great presentations and discussions. And easy access - no travel !! Stay tuned for the #EADays – VAS-INT 2026 meeting, which will take place virtually from 27 to 29 November, 2026. #VASCERN #VASCAPA #HEVAS #CMTC #ISSVA #NAVBO #EVBO 010
Miikka Vikkula @mvikkula.bsky.social · 15/12/2025Congratulations to all 3 young investigators who received the 1st International Joint Young Investigator/Clinician Awards in #Vascular #Medicine during the virtual #European #Angiology Days 2025 Dr #Annegret Holm, Dr J Mangulabnan, and Dr Anne Miralles-Amora. #VASCERN #VASCA #VASCAPA #HEVAS #CMTC 020
Miikka Vikkula @mvikkula.bsky.social · 15/12/2025Congratulations Peyman for the identification of associations between #variants in #spliceosomal genes and the occurrence of #cleft #lip and #palate. A #complex disease and #heterogeneous underlying pathophysiology. #Radiorg #eurordis #CLP #WELRI onlinelibrary.wiley.com/journal/humu/ 010
Miikka Vikkula @mvikkula.bsky.social · 05/12/2025Great 2 days at #French Society of #Lymphology in Toulouse on lymphatic malformations, lymphoedema and lipedema. Illustrative presentations, pertinent questions and collegial discussions. Humbling to be part of the faculty. #vascapa #hevas #CMTC #Welbio #eshg #revamp #VASCERN #eurordis #lymph #LM 030
Miikka Vikkula @mvikkula.bsky.social · 04/12/2025What a great session at the #BRAIN 2025 in London on fast-flow vascular malformations in the brain. Intense discussions and data sharing. Humbling to be part of the faculty. #vascapa #hevas #CMTC #Welbio #eshg #revamp #VASCERN #eurordis #Radiorg 000
Miikka Vikkula @mvikkula.bsky.social · 07/11/2025Great two sessions this morning at the mammouth size 2025 #AHA on various aspects of lymphatic and vascular situations of interest to cardiologists. Naturally I was addressing the #genetic basis and pathophysiology of #primary #lymphedema. #vascern #eshg #hevas #cmtc #welbio #theralymp #lymph 010
Miikka Vikkula @mvikkula.bsky.social · 02/11/2025So happy to have been able to teach about genetics and theragnostics on vascular anomalies at the 18th European Course in Neuroradiology. An extensive, high level course for all those interested in specialising in the field. Humbling to be part of the faculty. 000
Miikka Vikkula @mvikkula.bsky.social · 29/10/2025Learning of complex regulatory affairs in rare disease field at World Orphan Drug Congress Amsterdam. Great to see #EMA discussing with clinicians, patients and industry. But a lot to be done to accelerate development of drugs for orphan diseases. #vascapa #welbio #hevas #cmtc #eshg #vascern #esl 010
Miikka Vikkula @mvikkula.bsky.social · 19/10/2025It was a great International Society of Lymphology conference in Antalya. Thank you for the great organisation Pinar. Lots of news ideas and new collaborations 🤩 000
Miikka Vikkula @mvikkula.bsky.social · 03/10/2025What a Great visit to the Mendel museum this afternoon. Atbthe the roots of Mendelian genetics. 010
Miikka Vikkula @mvikkula.bsky.social · 03/10/2025So happy to be part of the Annual Pediatric Hématome -Oncology meeting of Czechia and Slovakia in Brno, the birth place of Mendelian Genetics 🤩 010
Miikka Vikkula @mvikkula.bsky.social · 03/10/2025Happy to be part of the annual pediatric hemato-Oncology meeting of Czechia and Slovakia. #vascern #vascapa #hevas #cmtc #issva 010
Miikka Vikkula @mvikkula.bsky.social · 15/06/2025It was again a great Lymphatic Forum, this time in Chicago. From basic lymphatic endothelial cell biology to clinical trials on lymphatic diseases. Looking forward to the 2027 one. 031
Miikka Vikkula @mvikkula.bsky.social · 09/05/2025If you are interested in the clinical aspects of lymphatic diseases, don't miss the 30th ISL World Congress of Lymphology. #lymph @vascern.bsky.social #issva #theralymph 032
Miikka Vikkula @mvikkula.bsky.social · 26/04/2025The great #ISSVA debates meeting 2025 meeting has come to an end. Nothing compares to F2F discussions and networking. Looking forward to the ISSVA World Congress 2026 in #Philadelphia #vascapa #hevas #CMTC #VASCERN #LE&RN #ESL #ISL #vascular #lymphatic #syndrome #hemangioma #theranostic #repurposing 042
Miikka Vikkula @mvikkula.bsky.social · 26/04/2025Great First European #Lymphatic Forum in Toulouse by #theralymph. Active participation by our group as well. Looking forward to the second edition in 2027 in #Budapest. #vascern #lymph #hevas #cmtc #le&rn #ESL #ISL #welbio 052
Miikka Vikkula @mvikkula.bsky.social · 26/04/2025#VASCERN participating in discussions on lymphatic diseases at the biannual Polish Lymphatic Meeting in Wroclaw. VASCERN has been referred to by several Polish speakers as well. 🤩 #vascapa #hevas #lymph #cmtc 022
Miikka Vikkula @mvikkula.bsky.social · 10/04/2025Great WCPD with several sessions on vascular anomalies. Launch of the Vascular Anomaly book with M. Cordisco, D. Teplisky and N. Torres as Editors. Happy to meet again the Garrahan Hospital VA-team and many other colleagues, to make progress the care of VAs. #VASCAPA, #HEVAS, #CMTC, #VASCERN, #LE&RN 032
Miikka Vikkula @mvikkula.bsky.social · 24/03/2025Interested in #vascular #biology and #diseases related to abnormal development. Our #review on #arteriovenous malformations and their therapeutic management was just published in JCI ! Extracranial arteriovenous malformations: towards etiology-based therapeutic management www.jci.org/articles/vie... 033
Miikka Vikkula @mvikkula.bsky.social · 25/02/2025Thank you #EURORDIS for the 2025 Black Pearl Scientific Award. It is so gratifying to witness the vigour exhibited by the rare disease community. Congratulations EURORDIS for your commitment to providing support to those affected by a rare disease. #VASCAPA #HEVAS VASCERN, @vascern.bsky.social ERN 081
Miikka Vikkula @mvikkula.bsky.social · 20/02/2025Three other interesting meetings in 2025 in Europe on vascular anomalies and lymphedema: #ISSVA debates and Updates,Paris (www.issva.org/2025); 1st European #Lymphatic Symposium,Toulouse (european-lymphatic-symposium.com), and the ISL World Congress of Lymphology, Antalya(www.isl2025lymphology.org). 033
Miikka Vikkula @mvikkula.bsky.social · 20/02/2025Three other interesting meetings in 2025 in Europe on vascular anomalies and lymphedema: #ISSVA debates and Updates,Paris (www.issva.org/2025); 1st European #Lymphatic Symposium,Toulouse (european-lymphatic-symposium.com), & the ISL World Congress of Lymphology,Antalya (www.isl2025lymphology.org). 032
Miikka Vikkula @mvikkula.bsky.social · 17/02/2025#VAC2025 is now over. Fantastic presentations with lively discussions from basic science to clinical applications. Congratulations to the poster award winners: Antonio Queiro Palou, Maya Alvared-Harmon, Apeksha Shapeti and Favour Onyeogaziri! See you in Barcelona 2027! #VASCERN #vascapa #HEVAS #cmtc 010
Miikka Vikkula @mvikkula.bsky.social · 06/02/2025International Conference on Vascular Anomalies: Translating basic research into new therapies (VAC 2025)! : lnkd.in/e6_BbzQF. Don't miss the event. The congress networking dinner nearly sold out! A few seats left for congress participation. lnkd.in/dzTfFVej #VASCAPA #HEVAS #CMTC #EVBO #ISSVA 042
Miikka Vikkula @mvikkula.bsky.social · 06/02/20254 days left before we the International Conference on Vascular Anomalies: Translating basic research into new therapies (VAC 2025)! Exciting program on novel preclinical models, drugs and results from clinical trials! lnkd.in/e6_BbzQF. Register at: lnkd.in/dzTfFVej #VASCAPA #HEVAS #CMTC #EVBO #ISSVA 010
Miikka Vikkula @mvikkula.bsky.social · 23/01/2025International Conference on Vascular Anomalies: Translating basic research into new therapies (VAC 2025)! : Exciting program, including novel preclinical models, drugs, and most recent results from clinical trials! lnkd.in/e6_BbzQF. Registrations: lnkd.in/dzTfFVej #VASCAPA #HEVAS #CMTC #EVBO #ISSVA 042
